AZITHROMYCIN DIHYDRATE

AZITHROMYCIN DIHYDRATE was reported 59749 times

AZITHROMYCIN DIHYDRATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NORMAL LABOUR 123 0.8786
1 VAGINAL FLATULENCE 170 0.5611
2 CONGENITAL HIATUS HERNIA 111 0.4868
3 TOTAL LUNG CAPACITY INCREASED 119 0.4375
4 PULMONARY VASCULITIS 199 0.3699
5 TOTAL LUNG CAPACITY ABNORMAL 140 0.3599
6 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 163 0.3117
7 CAPILLARITIS 68 0.2464
8 SPIROMETRY ABNORMAL 128 0.2140
9 DELIVERY 133 0.2018
10 MITE ALLERGY 122 0.1863
11 MYCOTIC ALLERGY 121 0.1415
12 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 98 0.1337
13 DUST ALLERGY 129 0.1315
14 MYCOBACTERIUM ABSCESSUS INFECTION 94 0.1315
15 MYCOBACTERIUM AVIUM COMPLEX INFECTION 350 0.1303
16 NEURITIS 193 0.1249
17 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 111 0.1197
18 FEMALE GENITAL TRACT FISTULA 177 0.1036
19 PULMONARY FUNCTION TEST ABNORMAL 161 0.1033
20 CONJUNCTIVITIS ALLERGIC 140 0.0945
21 ABORTION INCOMPLETE 170 0.0913
22 BRONCHIECTASIS 607 0.0900
23 CHRONIC SINUSITIS 337 0.0897
24 RESPIRATORY SYMPTOM 240 0.0843
25 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 164 0.0804
26 BREATH SOUNDS ABNORMAL 393 0.0796
27 FORCED EXPIRATORY VOLUME DECREASED 225 0.0793
28 RHINITIS ALLERGIC 352 0.0790
29 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 81 0.0763
30 RADICULOPATHY 198 0.0751
31 PROCTITIS 190 0.0678
32 BILIARY DYSKINESIA 114 0.0671
33 CYSTIC FIBROSIS 365 0.0659
34 BRONCHIAL WALL THICKENING 47 0.0654
35 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 350 0.0642
36 HYPERPARATHYROIDISM SECONDARY 160 0.0638
37 TOTAL LUNG CAPACITY DECREASED 101 0.0632
38 NEPHROGENIC ANAEMIA 281 0.0606
39 PULMONARY CAVITATION 52 0.0598
40 MALIGNANT MELANOMA IN SITU 74 0.0597
41 NASAL POLYPS 294 0.0596
42 RHONCHI 82 0.0593
43 OBSTRUCTIVE AIRWAYS DISORDER 654 0.0587
44 MYCOBACTERIAL INFECTION 101 0.0586
45 BONE DEMINERALISATION 61 0.0576
46 ATYPICAL MYCOBACTERIAL INFECTION 81 0.0572
47 FULL BLOOD COUNT ABNORMAL 599 0.0566
48 IMMUNE RECONSTITUTION SYNDROME 72 0.0558
49 LUNG OPACITY 141 0.0534
50 OTOTOXICITY 97 0.0524
51 MACULAR DEGENERATION 615 0.0514
52 CHEST X-RAY ABNORMAL 155 0.0505
53 REBOUND ACID HYPERSECRETION 148 0.0489
54 SPUTUM DISCOLOURED 464 0.0489
55 SPUTUM INCREASED 105 0.0485
56 BRONCHIAL HYPERREACTIVITY 56 0.0466
57 CHOLECYSTITIS CHRONIC 311 0.0464
58 STENOTROPHOMONAS INFECTION 62 0.0457
59 RALES 259 0.0446
60 NORMOCHROMIC NORMOCYTIC ANAEMIA 132 0.0439
61 PULMONARY ALVEOLAR HAEMORRHAGE 240 0.0427
62 PNEUMONIA PSEUDOMONAL 63 0.0410
63 BRONCHIAL SECRETION RETENTION 52 0.0408
64 NEUROLOGICAL SYMPTOM 209 0.0365
65 PULMONARY FUNCTION TEST DECREASED 158 0.0361
66 PLEURITIC PAIN 99 0.0358
67 OBSTRUCTIVE SLEEP APNOEA SYNDROME 52 0.0356
68 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 599 0.0352
69 ACUTE SINUSITIS 60 0.0348
70 EAR PRURITUS 122 0.0348
71 JAUNDICE CHOLESTATIC 117 0.0331
72 DEAFNESS NEUROSENSORY 106 0.0322
73 UPPER-AIRWAY COUGH SYNDROME 265 0.0321
74 INFUSION SITE DISCHARGE 56 0.0319
75 END STAGE RENAL DISEASE 577 0.0316
76 GALLBLADDER INJURY 61 0.0313
77 TACHYARRHYTHMIA 75 0.0300
78 VASCULITIS 349 0.0299
79 SARCOIDOSIS 142 0.0299
80 PULMONARY INFARCTION 70 0.0296
81 BENIGN PROSTATIC HYPERPLASIA 149 0.0288
82 DEAFNESS BILATERAL 49 0.0288
83 ECONOMIC PROBLEM 436 0.0287
84 PNEUMATOSIS INTESTINALIS 82 0.0287
85 WHEEZING 1669 0.0281
86 ESSENTIAL HYPERTENSION 51 0.0278
87 ORAL CANDIDIASIS 366 0.0278
88 ARTERIOSCLEROSIS CORONARY ARTERY 184 0.0277
89 CARDIAC MURMUR 240 0.0277
90 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 72 0.0270
91 HAEMOPTYSIS 751 0.0269
92 ACTINIC KERATOSIS 69 0.0266
93 ISCHAEMIC CARDIOMYOPATHY 81 0.0264
94 CHRONIC KIDNEY DISEASE 1976 0.0260
95 INFUSION SITE BRUISING 55 0.0254
96 PRODUCTIVE COUGH 1214 0.0254
97 HYPOMANIA 91 0.0247
98 PSEUDOMONAS INFECTION 209 0.0243
99 PREMATURE DELIVERY 387 0.0243
100 BLOOD LACTIC ACID INCREASED 128 0.0243
101 INCREASED BRONCHIAL SECRETION 62 0.0242
102 MUCORMYCOSIS 62 0.0238
103 HYPERCAPNIA 71 0.0235
104 DILATATION VENTRICULAR 48 0.0228
105 ANHEDONIA 599 0.0228
106 SINUS PAIN 52 0.0223
107 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 108 0.0217
108 RHINOVIRUS INFECTION 82 0.0210
109 PULMONARY FIBROSIS 404 0.0210
110 ARTERIOSCLEROSIS 195 0.0207
111 THROMBOPHLEBITIS SUPERFICIAL 62 0.0204
112 HALLUCINATIONS, MIXED 86 0.0204
113 LEFT VENTRICULAR HYPERTROPHY 86 0.0201
114 BLOOD PRESSURE SYSTOLIC ABNORMAL 49 0.0198
115 MULTIPLE-DRUG RESISTANCE 61 0.0197
116 INFUSION SITE PRURITUS 62 0.0196
117 VAGINAL DISCHARGE 198 0.0195
118 ASTHMA 2198 0.0194
119 LUNG NEOPLASM 82 0.0192
120 ATELECTASIS 185 0.0191
121 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 998 0.0191
122 THERAPEUTIC AGENT TOXICITY 63 0.0189
123 PARAESTHESIA ORAL 271 0.0188
124 OTITIS MEDIA 62 0.0187
125 PNEUMONIA BACTERIAL 172 0.0187
126 HYPOXIA 659 0.0187
127 LUNG CONSOLIDATION 52 0.0186
128 ASPERGILLUS INFECTION 122 0.0186
129 PATHOGEN RESISTANCE 166 0.0182
130 EOSINOPHILIA 317 0.0181
131 LUNG INFILTRATION 159 0.0180
132 ELECTROCARDIOGRAM QT PROLONGED 647 0.0180
133 HYPERCHOLESTEROLAEMIA 173 0.0179
134 UPPER RESPIRATORY TRACT INFECTION 826 0.0179
135 FLANK PAIN 167 0.0178
136 CREPITATIONS 53 0.0178
137 CANDIDIASIS 71 0.0177
138 MULTIPLE INJURIES 111 0.0176
139 IMPAIRED QUALITY OF LIFE 253 0.0176
140 TRICUSPID VALVE INCOMPETENCE 139 0.0175
141 ACUTE RESPIRATORY FAILURE 335 0.0174
142 OESOPHAGEAL CANDIDIASIS 68 0.0170
143 RESPIRATION ABNORMAL 117 0.0170
144 WOUND COMPLICATION 58 0.0169
145 LIP OEDEMA 71 0.0167
146 LUNG DISORDER 818 0.0167
147 PARANASAL SINUS DISCOMFORT 63 0.0166
148 PATENT DUCTUS ARTERIOSUS 66 0.0166
149 BILIARY COLIC 48 0.0165
150 PULMONARY MASS 245 0.0164
151 DYSPNOEA EXERTIONAL 618 0.0164
152 TOXIC EPIDERMAL NECROLYSIS 249 0.0164
153 BRONCHOPULMONARY ASPERGILLOSIS 125 0.0161
154 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 773 0.0161
155 ORTHOPNOEA 51 0.0160
156 INFUSION SITE HAEMORRHAGE 52 0.0158
157 TORSADE DE POINTES 124 0.0158
158 RESPIRATORY TRACT INFECTION 411 0.0158
159 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 861 0.0157
160 PNEUMONIA VIRAL 50 0.0157
161 MASTICATION DISORDER 48 0.0157
162 DRUG RESISTANCE 401 0.0156
163 BRONCHITIS 1147 0.0155
164 SUSPECTED OFF LABEL USE 70 0.0155
165 PNEUMONIA FUNGAL 61 0.0154
166 OBESITY 246 0.0154
167 HYPERLIPIDAEMIA 183 0.0153
168 OSTEOPENIA 232 0.0153
169 INFUSION SITE SWELLING 96 0.0152
170 LUNG TRANSPLANT 54 0.0152
171 MULTIPLE ALLERGIES 119 0.0152
172 EMPHYSEMA 153 0.0152
173 EOSINOPHIL COUNT INCREASED 126 0.0151
174 GASTROOESOPHAGEAL REFLUX DISEASE 1213 0.0151
175 AORTIC VALVE INCOMPETENCE 64 0.0150
176 PREMATURE BABY 452 0.0150
177 ORGANISING PNEUMONIA 74 0.0149
178 ODYNOPHAGIA 89 0.0149
179 STEVENS-JOHNSON SYNDROME 331 0.0149
180 LOW BIRTH WEIGHT BABY 117 0.0147
181 MITRAL VALVE INCOMPETENCE 165 0.0146
182 SPINAL OSTEOARTHRITIS 127 0.0144
183 SECRETION DISCHARGE 181 0.0144
184 SEASONAL ALLERGY 203 0.0143
185 INJURY 1007 0.0143
186 ACUTE RESPIRATORY DISTRESS SYNDROME 253 0.0143
187 GALLBLADDER DISORDER 255 0.0143
188 RENAL TUBULAR NECROSIS 140 0.0143
189 EXERCISE TOLERANCE DECREASED 82 0.0142
190 SUPRAVENTRICULAR EXTRASYSTOLES 48 0.0142
191 PHARYNGITIS 175 0.0141
192 SINUS CONGESTION 190 0.0140
193 INFUSION SITE ERYTHEMA 118 0.0140
194 COVID-19 PNEUMONIA 165 0.0140
195 BRONCHIOLITIS 49 0.0139
196 TUBULOINTERSTITIAL NEPHRITIS 260 0.0139
197 DEAFNESS 362 0.0138
198 MATERNAL EXPOSURE TIMING UNSPECIFIED 52 0.0138
199 THERMAL BURN 98 0.0138
200 HYPERTRANSAMINASAEMIA 96 0.0138
201 CARDIOMEGALY 168 0.0136
202 DEPRESSIVE SYMPTOM 48 0.0136
203 CHOLECYSTITIS ACUTE 77 0.0136
204 CHOLELITHIASIS 444 0.0135
205 ATRIAL SEPTAL DEFECT 113 0.0135
206 SNORING 51 0.0135
207 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 950 0.0133
208 CEREBRAL ATROPHY 53 0.0133
209 PULMONARY CONGESTION 175 0.0133
210 CLOSTRIDIUM DIFFICILE COLITIS 140 0.0132
211 ASTHMATIC CRISIS 48 0.0131
212 NODULE 171 0.0131
213 HEPATIC CYTOLYSIS 165 0.0129
214 EAR DISORDER 59 0.0129
215 RESPIRATORY SYNCYTIAL VIRUS INFECTION 112 0.0128
216 INTERVERTEBRAL DISC DEGENERATION 119 0.0128
217 RHINITIS 103 0.0128
218 ANOSMIA 183 0.0126
219 PHARYNGOLARYNGEAL PAIN 67 0.0126
220 RENAL CYST 100 0.0126
221 TONGUE DISCOLOURATION 55 0.0126
222 CACHEXIA 64 0.0124
223 PNEUMOTHORAX 196 0.0123
224 RENAL FAILURE CHRONIC 95 0.0123
225 RESPIRATORY TRACT CONGESTION 195 0.0123
226 SINUSITIS 1255 0.0122
227 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 95 0.0122
228 TACHYPNOEA 165 0.0121
229 ABDOMINAL TENDERNESS 60 0.0121
230 ASPIRATION 132 0.0120
231 GOITRE 49 0.0120
232 PLATELET COUNT INCREASED 156 0.0120
233 ACUTE KIDNEY INJURY 1829 0.0119
234 ECCHYMOSIS 81 0.0118
235 CHOLECYSTITIS 140 0.0117
236 DYSPHONIA 677 0.0116
237 LYMPHOEDEMA 80 0.0116
238 MICTURITION URGENCY 132 0.0115
239 HIATUS HERNIA 149 0.0115
240 LEUKOCYTOSIS 207 0.0114
241 INFUSION SITE PAIN 147 0.0114
242 DECREASED ACTIVITY 123 0.0114
243 SWOLLEN TONGUE 355 0.0114
244 TINNITUS 521 0.0113
245 BUNDLE BRANCH BLOCK LEFT 48 0.0113
246 APPETITE DISORDER 75 0.0113
247 BRONCHOSPASM 161 0.0113
248 HYPOGAMMAGLOBULINAEMIA 74 0.0113
249 SINUS DISORDER 223 0.0112
250 COUGH 3147 0.0112
251 VENTRICULAR SEPTAL DEFECT 64 0.0112
252 FAILURE TO THRIVE 58 0.0112
253 RENAL FAILURE 1476 0.0111
254 PULMONARY EMBOLISM 1051 0.0110
255 RESPIRATORY DISTRESS 305 0.0110
256 INCORRECT DRUG ADMINISTRATION RATE 47 0.0110
257 EAR DISCOMFORT 113 0.0110
258 HEARING IMPAIRED 66 0.0110
259 ENTEROCOCCAL INFECTION 53 0.0110
260 STREPTOCOCCAL INFECTION 61 0.0110
261 LOWER RESPIRATORY TRACT INFECTION 497 0.0109
262 DIVERTICULUM 77 0.0108
263 CHOLESTASIS 207 0.0108
264 RENAL INJURY 320 0.0108
265 BLOOD CALCIUM INCREASED 94 0.0107
266 DEAFNESS UNILATERAL 59 0.0107
267 CORONARY ARTERY DISEASE 324 0.0107
268 HYPERVENTILATION 62 0.0107
269 RESPIRATORY FAILURE 777 0.0106
270 NASAL CONGESTION 625 0.0106
271 HEPATOMEGALY 104 0.0106
272 VENTRICULAR TACHYCARDIA 174 0.0105
273 EAR PAIN 204 0.0105
274 HEPATITIS CHOLESTATIC 63 0.0104
275 DYSLIPIDAEMIA 53 0.0104
276 BACTERIAL INFECTION 194 0.0104
277 SLEEP APNOEA SYNDROME 198 0.0104
278 RESPIRATORY DISORDER 310 0.0104
279 DEEP VEIN THROMBOSIS 671 0.0103
280 ELECTROCARDIOGRAM ABNORMAL 81 0.0103
281 SQUAMOUS CELL CARCINOMA OF SKIN 62 0.0103
282 SNEEZING 228 0.0102
283 PNEUMONIA 3291 0.0102
284 EAR INFECTION 269 0.0101
285 PERIPHERAL VASCULAR DISORDER 52 0.0101
286 RASH MACULO-PAPULAR 224 0.0101
287 RESPIRATORY RATE INCREASED 89 0.0100
288 BUNDLE BRANCH BLOCK RIGHT 46 0.0100
289 CARDIOMYOPATHY 148 0.0100
290 HEPATITIS ACUTE 65 0.0100
291 VENTRICULAR FIBRILLATION 111 0.0100
292 CHEST DISCOMFORT 1023 0.0100
293 HYPOTHYROIDISM 316 0.0099
294 GINGIVITIS 53 0.0098
295 OXYGEN SATURATION DECREASED 552 0.0098
296 VENTRICULAR EXTRASYSTOLES 102 0.0098
297 ORAL DISORDER 72 0.0098
298 DRUG-INDUCED LIVER INJURY 306 0.0097
299 SUPRAVENTRICULAR TACHYCARDIA 93 0.0097
300 TRANSAMINASES INCREASED 216 0.0097
301 RHINORRHOEA 625 0.0097
302 PROCEDURAL PAIN 267 0.0096
303 OSTEOPOROSIS 395 0.0096
304 APHONIA 134 0.0096
305 DRUG ERUPTION 170 0.0096
306 VIRAL INFECTION 319 0.0096
307 POST-TRAUMATIC STRESS DISORDER 64 0.0095
308 PROTHROMBIN TIME PROLONGED 57 0.0095
309 STILLBIRTH 46 0.0095
310 SENSITIVITY TO WEATHER CHANGE 50 0.0095
311 INSURANCE ISSUE 145 0.0095
312 NASAL DRYNESS 59 0.0094
313 SINUS BRADYCARDIA 91 0.0094
314 FREQUENT BOWEL MOVEMENTS 254 0.0094
315 PNEUMOCYSTIS JIROVECII PNEUMONIA 94 0.0094
316 INCREASED UPPER AIRWAY SECRETION 48 0.0093
317 PATHOLOGICAL FRACTURE 47 0.0093
318 FOETAL DEATH 48 0.0092
319 PHARYNGITIS STREPTOCOCCAL 100 0.0092
320 VITAMIN D DEFICIENCY 90 0.0092
321 PAPULE 65 0.0092
322 HYPERTRIGLYCERIDAEMIA 54 0.0092
323 MALNUTRITION 102 0.0091
324 HYPERVOLAEMIA 45 0.0091
325 KLEBSIELLA INFECTION 46 0.0091
326 BLOOD BILIRUBIN INCREASED 245 0.0091
327 HYPERKERATOSIS 50 0.0091
328 DRUG INTERACTION 1428 0.0090
329 HEPATIC STEATOSIS 167 0.0090
330 SINUS TACHYCARDIA 127 0.0089
331 HAEMATOCRIT DECREASED 177 0.0089
332 TENDERNESS 93 0.0089
333 SINUS HEADACHE 53 0.0089
334 CANDIDA INFECTION 150 0.0089
335 PULMONARY HYPERTENSION 185 0.0089
336 INTERNATIONAL NORMALISED RATIO INCREASED 253 0.0089
337 SCHIZOPHRENIA 107 0.0088
338 HEPATOTOXICITY 196 0.0088
339 STAPHYLOCOCCAL INFECTION 290 0.0088
340 NEPHROPATHY 82 0.0088
341 HERPES SIMPLEX 57 0.0088
342 BLOOD ALKALINE PHOSPHATASE INCREASED 217 0.0087
343 BODY TEMPERATURE DECREASED 86 0.0087
344 MATERNAL EXPOSURE DURING PREGNANCY 778 0.0087
345 EMOTIONAL DISTRESS 1049 0.0087
346 PRE-EXISTING CONDITION IMPROVED 54 0.0086
347 ATRIAL FLUTTER 69 0.0086
348 QUALITY OF LIFE DECREASED 116 0.0086
349 SKIN LACERATION 94 0.0086
350 PULMONARY TOXICITY 61 0.0086
351 DRUG INTOLERANCE 831 0.0086
352 PLEURISY 51 0.0086
353 DENTAL CARIES 95 0.0086
354 RENAL FAILURE ACUTE 364 0.0086
355 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 219 0.0085
356 HYPERBILIRUBINAEMIA 88 0.0085
357 DERMATITIS CONTACT 96 0.0084
358 CYANOSIS 132 0.0084
359 INFUSION SITE EXTRAVASATION 52 0.0083
360 AGEUSIA 208 0.0083
361 DYSPNOEA 4719 0.0083
362 HEPATOCELLULAR INJURY 118 0.0083
363 COLITIS 315 0.0083
364 MULTI-ORGAN FAILURE 143 0.0083
365 MUSCULOSKELETAL CHEST PAIN 128 0.0083
366 CONGENITAL ANOMALY 64 0.0083
367 SWELLING FACE 538 0.0083
368 LEFT VENTRICULAR DYSFUNCTION 55 0.0082
369 PULMONARY HAEMORRHAGE 64 0.0082
370 TENDONITIS 126 0.0081
371 GASTRITIS 214 0.0081
372 BLOOD POTASSIUM DECREASED 244 0.0081
373 BLOOD PRESSURE SYSTOLIC INCREASED 158 0.0081
374 MULTIPLE ORGAN DYSFUNCTION SYNDROME 229 0.0081
375 TOOTH ABSCESS 82 0.0080
376 JOINT INJURY 172 0.0080
377 CARDIAC VALVE DISEASE 46 0.0080
378 BLOOD TEST ABNORMAL 113 0.0080
379 ERYTHEMA MULTIFORME 75 0.0080
380 PLEURAL EFFUSION 488 0.0080
381 ANXIETY 2275 0.0080
382 TRANSPLANT REJECTION 64 0.0080
383 IMMUNOSUPPRESSION 70 0.0079
384 HAEMOLYTIC ANAEMIA 71 0.0079
385 OROPHARYNGEAL PAIN 725 0.0078
386 TENDON DISORDER 51 0.0078
387 IRON DEFICIENCY ANAEMIA 72 0.0078
388 OSTEOARTHRITIS 330 0.0078
389 EXOSTOSIS 71 0.0078
390 PNEUMONITIS 211 0.0077
391 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 58 0.0077
392 INFLUENZA 860 0.0077
393 ANGIOEDEMA 341 0.0077
394 OESOPHAGITIS 84 0.0077
395 BONE DISORDER 140 0.0077
396 SPINAL COMPRESSION FRACTURE 63 0.0076
397 CHOLECYSTECTOMY 87 0.0076
398 GLUCOSE TOLERANCE IMPAIRED 45 0.0076
399 BACTERAEMIA 90 0.0076
400 BLOOD ALBUMIN DECREASED 60 0.0076
401 GASTROENTERITIS 110 0.0075
402 ENCEPHALITIS 52 0.0075
403 WRIST FRACTURE 90 0.0075
404 FUNGAL INFECTION 250 0.0075
405 BODY TEMPERATURE INCREASED 152 0.0074
406 EXTRASYSTOLES 52 0.0074
407 MENTAL STATUS CHANGES 206 0.0074
408 IMPAIRED GASTRIC EMPTYING 101 0.0074
409 PRODUCT ADMINISTRATION INTERRUPTED 58 0.0074
410 AGRANULOCYTOSIS 137 0.0074
411 OBSESSIVE-COMPULSIVE DISORDER 59 0.0073
412 LUNG INFECTION 114 0.0073
413 RECTAL HAEMORRHAGE 314 0.0073
414 CONDITION AGGRAVATED 2218 0.0073
415 PAROSMIA 55 0.0073
416 TRANSIENT ISCHAEMIC ATTACK 245 0.0073
417 ANGINA UNSTABLE 47 0.0072
418 RIB FRACTURE 148 0.0072
419 AUTOIMMUNE HEPATITIS 50 0.0072
420 CONJUNCTIVITIS 133 0.0072
421 DEFORMITY 67 0.0072
422 HAEMATOCHEZIA 395 0.0071
423 DYSPEPSIA 704 0.0071
424 OEDEMA PERIPHERAL 870 0.0071
425 MIDDLE INSOMNIA 133 0.0071
426 GRAFT VERSUS HOST DISEASE 51 0.0071
427 UTERINE PERFORATION 60 0.0071
428 SKIN LESION 194 0.0071
429 ACIDOSIS 54 0.0071
430 HAND FRACTURE 50 0.0071
431 CHEST PAIN 1306 0.0070
432 FEAR 189 0.0070
433 HEART RATE IRREGULAR 158 0.0070
434 INFECTION 1012 0.0070
435 GASTROENTERITIS VIRAL 126 0.0070
436 COLITIS ISCHAEMIC 47 0.0070
437 ABDOMINAL PAIN 1620 0.0070
438 HAEMODYNAMIC INSTABILITY 53 0.0069
439 BLOOD CREATININE INCREASED 454 0.0069
440 PYREXIA 2406 0.0069
441 RHABDOMYOLYSIS 288 0.0069
442 DRY THROAT 70 0.0069
443 HEPATIC FAILURE 207 0.0069
444 RASH PUSTULAR 50 0.0069
445 ROTATOR CUFF SYNDROME 88 0.0068
446 MAJOR DEPRESSION 50 0.0068
447 LYMPHADENOPATHY 242 0.0068
448 SCAR 117 0.0068
449 ACUTE HEPATIC FAILURE 93 0.0068
450 JAUNDICE 181 0.0067
451 FACIAL PAIN 60 0.0067
452 NEUTROPENIC SEPSIS 48 0.0067
453 RED BLOOD CELL SEDIMENTATION RATE INCREASED 74 0.0067
454 NASAL DISCOMFORT 53 0.0067
455 ADRENAL INSUFFICIENCY 81 0.0067
456 LIGAMENT SPRAIN 66 0.0067
457 DUODENAL ULCER 47 0.0067
458 COVID-19 1168 0.0067
459 LACRIMATION INCREASED 201 0.0066
460 RASH ERYTHEMATOUS 318 0.0066
461 DRUG LEVEL INCREASED 110 0.0066
462 HEPATITIS 170 0.0066
463 GENERALISED OEDEMA 82 0.0066
464 PRODUCT USE IN UNAPPROVED INDICATION 1630 0.0066
465 IMMUNODEFICIENCY 97 0.0065
466 BLOOD PRESSURE DIASTOLIC DECREASED 48 0.0065
467 PERICARDIAL EFFUSION 150 0.0065
468 INFUSION RELATED REACTION 429 0.0065
469 FACE OEDEMA 109 0.0065
470 PURPURA 57 0.0064
471 BURSITIS 78 0.0064
472 PANCYTOPENIA 359 0.0064
473 HAEMORRHOIDS 125 0.0064
474 PALLOR 174 0.0064
475 DISSEMINATED INTRAVASCULAR COAGULATION 90 0.0064
476 ANAEMIA 1219 0.0064
477 FOETAL EXPOSURE DURING PREGNANCY 519 0.0064
478 COAGULOPATHY 106 0.0064
479 INTERVERTEBRAL DISC PROTRUSION 139 0.0064
480 ASPARTATE AMINOTRANSFERASE INCREASED 336 0.0063
481 ALANINE AMINOTRANSFERASE INCREASED 386 0.0063
482 ELECTROLYTE IMBALANCE 73 0.0063
483 ANGINA PECTORIS 180 0.0063
484 BIPOLAR DISORDER 68 0.0062
485 MYOPATHY 54 0.0062
486 PHOTOSENSITIVITY REACTION 103 0.0062
487 ILLNESS 642 0.0062
488 HAEMOLYSIS 48 0.0062
489 WEIGHT DECREASED 1734 0.0062
490 TEMPERATURE INTOLERANCE 64 0.0062
491 HEART RATE INCREASED 614 0.0062
492 COLITIS ULCERATIVE 276 0.0062
493 BLOOD UREA INCREASED 103 0.0061
494 HYDRONEPHROSIS 46 0.0061
495 URTICARIA 1028 0.0061
496 MYOSITIS 55 0.0061
497 BONE DENSITY DECREASED 192 0.0061
498 ATRIAL FIBRILLATION 596 0.0061
499 CHROMATURIA 138 0.0061
500 HALLUCINATION, VISUAL 129 0.0061
501 TACHYCARDIA 541 0.0061
502 RENAL IMPAIRMENT 511 0.0061
503 OSTEOMYELITIS 110 0.0061
504 APHTHOUS ULCER 47 0.0061
505 BLOOD SODIUM DECREASED 114 0.0060
506 HYPERSENSITIVITY 1121 0.0060
507 PSYCHOTIC DISORDER 178 0.0060
508 NIGHT SWEATS 194 0.0060
509 LIVER FUNCTION TEST INCREASED 129 0.0060
510 THROAT IRRITATION 269 0.0060
511 SPLENOMEGALY 70 0.0060
512 THERAPY NON-RESPONDER 268 0.0060
513 OFF LABEL USE 5213 0.0059
514 PRODUCT DISTRIBUTION ISSUE 55 0.0059
515 HALLUCINATION, AUDITORY 94 0.0059
516 SLEEP DISORDER 417 0.0059
517 SEPTIC SHOCK 257 0.0059
518 MUSCLE STRAIN 51 0.0059
519 EYE PRURITUS 197 0.0059
520 PREGNANCY 117 0.0058
521 EMOTIONAL DISORDER 180 0.0058
522 OEDEMA 316 0.0058
523 NASOPHARYNGITIS 1074 0.0058
524 ANURIA 50 0.0058
525 ACTIVITIES OF DAILY LIVING IMPAIRED 115 0.0058
526 ABDOMINAL PAIN LOWER 146 0.0058
527 SHOCK 132 0.0057
528 PALPITATIONS 671 0.0057
529 CARDIAC FAILURE CONGESTIVE 459 0.0057
530 HYPOKALAEMIA 263 0.0057
531 MYASTHENIA GRAVIS 46 0.0057
532 PHARYNGEAL OEDEMA 87 0.0056
533 CARDIAC ARREST 466 0.0056
534 DISEASE RECURRENCE 268 0.0056
535 GENERAL PHYSICAL HEALTH DETERIORATION 651 0.0056
536 BLOOD LACTATE DEHYDROGENASE INCREASED 89 0.0056
537 CELLULITIS 283 0.0056
538 HAEMATURIA 192 0.0056
539 HEPATIC ENZYME INCREASED 381 0.0056
540 PANCREATITIS ACUTE 125 0.0056
541 ANAPHYLACTIC SHOCK 143 0.0055
542 ENCEPHALOPATHY 136 0.0055
543 MYOCARDIAL ISCHAEMIA 63 0.0055
544 RETCHING 118 0.0055
545 POOR VENOUS ACCESS 57 0.0055
546 CARPAL TUNNEL SYNDROME 77 0.0055
547 MENTAL DISORDER 239 0.0055
548 WHITE BLOOD CELL COUNT INCREASED 210 0.0055
549 INTENTIONAL DOSE OMISSION 156 0.0055
550 FIBROMYALGIA 133 0.0055
551 BRAIN OEDEMA 69 0.0055
552 SEPSIS 609 0.0055
553 EYELID OEDEMA 63 0.0054
554 THERAPY INTERRUPTED 387 0.0054
555 FAECES DISCOLOURED 117 0.0054
556 OPTIC NEURITIS 49 0.0054
557 PULMONARY OEDEMA 241 0.0054
558 PAIN 3297 0.0054
559 GASTROINTESTINAL PAIN 59 0.0054
560 THROMBOSIS 431 0.0054
561 MULTIPLE FRACTURES 88 0.0054
562 DEPRESSION 1218 0.0053
563 GOUT 96 0.0053
564 HYPERCALCAEMIA 66 0.0053
565 ANAPHYLACTIC REACTION 295 0.0053
566 LIVER FUNCTION TEST ABNORMAL 155 0.0053
567 GASTROINTESTINAL DISORDER 477 0.0053
568 OROPHARYNGEAL DISCOMFORT 48 0.0053
569 NEPHROLITHIASIS 243 0.0053
570 DYSURIA 195 0.0053
571 TREATMENT NONCOMPLIANCE 289 0.0053
572 FOOT FRACTURE 100 0.0053
573 MOUTH ULCERATION 111 0.0053
574 METABOLIC ACIDOSIS 168 0.0052
575 ORAL DISCOMFORT 73 0.0052
576 ABDOMINAL PAIN UPPER 1080 0.0052
577 FOLLICULITIS 55 0.0052
578 CYSTITIS 167 0.0052
579 BRADYCARDIA 278 0.0052
580 MUSCULOSKELETAL DISCOMFORT 90 0.0052
581 ORAL HERPES 102 0.0052
582 UPPER LIMB FRACTURE 104 0.0052
583 HYPERTENSION 1105 0.0052
584 LIVER INJURY 128 0.0052
585 EJECTION FRACTION DECREASED 81 0.0052
586 IRRITABLE BOWEL SYNDROME 111 0.0052
587 CLOSTRIDIUM DIFFICILE INFECTION 113 0.0052
588 SKIN INFECTION 58 0.0052
589 BLOOD TRIGLYCERIDES INCREASED 91 0.0051
590 GAMMA-GLUTAMYLTRANSFERASE INCREASED 114 0.0051
591 SCIATICA 82 0.0051
592 JOINT DISLOCATION 54 0.0051
593 TOOTH INFECTION 67 0.0051
594 HEART RATE DECREASED 178 0.0051
595 DEVICE RELATED INFECTION 78 0.0051
596 TOXIC SKIN ERUPTION 51 0.0051
597 BLOOD PRESSURE FLUCTUATION 121 0.0050
598 HYPERKALAEMIA 176 0.0050
599 MASS 70 0.0050
600 COELIAC DISEASE 49 0.0050
601 NECK PAIN 279 0.0050
602 PRODUCT DOSE OMISSION IN ERROR 141 0.0050
603 TOOTHACHE 90 0.0050
604 VOMITING 2327 0.0049
605 CARDIOGENIC SHOCK 71 0.0049
606 MYOCLONUS 59 0.0049
607 DRUG EXPOSURE DURING PREGNANCY 167 0.0049
608 THROMBOCYTOPENIA 549 0.0049
609 EXPOSURE DURING PREGNANCY 305 0.0049
610 TOOTH FRACTURE 54 0.0049
611 PRESYNCOPE 119 0.0049
612 HYPERGLYCAEMIA 177 0.0049
613 PANIC ATTACK 177 0.0049
614 DIZZINESS POSTURAL 47 0.0048
615 ULCER 77 0.0048
616 CYTOPENIA 59 0.0048
617 DIARRHOEA HAEMORRHAGIC 45 0.0048
618 NEPHROPATHY TOXIC 54 0.0048
619 BLOOD POTASSIUM INCREASED 78 0.0048
620 WOUND 134 0.0048
621 IMMUNE SYSTEM DISORDER 63 0.0048
622 CHILLS 560 0.0048
623 DERMATITIS ALLERGIC 60 0.0048
624 COLD SWEAT 84 0.0048
625 BLOOD CHOLESTEROL INCREASED 222 0.0048
626 LYMPHOPENIA 67 0.0047
627 CONSTIPATION 1029 0.0047
628 PHARYNGEAL SWELLING 46 0.0047
629 LUNG NEOPLASM MALIGNANT 193 0.0047
630 ARTHRITIS 369 0.0047
631 RASH 2036 0.0047
632 RASH PRURITIC 253 0.0047
633 ILEUS 58 0.0047
634 DIALYSIS 66 0.0046
635 DYSPHAGIA 441 0.0046
636 DIARRHOEA 2999 0.0046
637 GLOMERULAR FILTRATION RATE DECREASED 57 0.0046
638 PETECHIAE 48 0.0046
639 BRAIN FOG 72 0.0046
640 PERIPHERAL COLDNESS 63 0.0046
641 TREMOR 761 0.0046
642 THROAT TIGHTNESS 124 0.0046
643 TOOTH LOSS 95 0.0046
644 CYTOMEGALOVIRUS INFECTION 76 0.0046
645 LIMB INJURY 124 0.0046
646 HYPONATRAEMIA 257 0.0046
647 FLUID OVERLOAD 66 0.0045
648 HYPOMAGNESAEMIA 63 0.0045
649 ASTHENIA 1696 0.0045
650 EATING DISORDER 96 0.0045
651 DISCOMFORT 275 0.0045
652 BACK INJURY 49 0.0045
653 BACK PAIN 1046 0.0045
654 INFLAMMATION 232 0.0045
655 DEHYDRATION 599 0.0045
656 ERYTHEMA 923 0.0045
657 ORTHOSTATIC HYPOTENSION 78 0.0045
658 SARS-COV-2 TEST POSITIVE 59 0.0045
659 HYPOPHAGIA 114 0.0045
660 URINARY TRACT INFECTION 760 0.0045
661 SYNCOPE 445 0.0044
662 DELIRIUM 154 0.0044
663 NAUSEA 3504 0.0044
664 HYPERHIDROSIS 570 0.0044
665 BASAL CELL CARCINOMA 69 0.0044
666 MALAISE 1939 0.0044
667 LEUKOPENIA 221 0.0044
668 WEIGHT FLUCTUATION 46 0.0044
669 ANKLE FRACTURE 68 0.0044
670 SMALL INTESTINAL OBSTRUCTION 54 0.0044
671 KIDNEY INFECTION 86 0.0044
672 DIABETES MELLITUS 334 0.0044
673 HYPOACUSIS 188 0.0044
674 TYPE 2 DIABETES MELLITUS 147 0.0044
675 NEUROPATHY PERIPHERAL 414 0.0043
676 ANOREXIA 56 0.0043
677 RESTLESS LEGS SYNDROME 79 0.0043
678 C-REACTIVE PROTEIN INCREASED 158 0.0043
679 PAIN IN JAW 123 0.0043
680 MUSCULOSKELETAL PAIN 227 0.0043
681 HYPOCALCAEMIA 82 0.0043
682 ORAL PAIN 97 0.0043
683 ARRHYTHMIA 205 0.0043
684 BLOOD PRESSURE ABNORMAL 86 0.0043
685 DYSGEUSIA 320 0.0043
686 CHOKING 84 0.0043
687 IMPAIRED WORK ABILITY 92 0.0043
688 BLOOD IRON DECREASED 51 0.0043
689 HALLUCINATION 323 0.0043
690 ACUTE MYOCARDIAL INFARCTION 126 0.0043
691 HEADACHE 2678 0.0043
692 DIVERTICULITIS 118 0.0043
693 INTERSTITIAL LUNG DISEASE 206 0.0043
694 HAEMATOMA 110 0.0042
695 CARDIO-RESPIRATORY ARREST 177 0.0042
696 HYPOTENSION 849 0.0042
697 ASCITES 124 0.0042
698 HAEMOGLOBIN DECREASED 433 0.0042
699 ABDOMINAL DISTENSION 439 0.0042
700 VERTIGO 256 0.0042
701 CATARACT 250 0.0042
702 CONVULSION 240 0.0042
703 PAIN IN EXTREMITY 1235 0.0042
704 RENAL DISORDER 195 0.0042
705 DEPRESSED MOOD 221 0.0042
706 BLOOD CALCIUM DECREASED 47 0.0042
707 ABDOMINAL DISCOMFORT 699 0.0042
708 EYE SWELLING 155 0.0042
709 RED BLOOD CELL COUNT DECREASED 119 0.0042
710 HAEMORRHAGE 435 0.0042
711 GASTRIC ULCER 79 0.0042
712 SKIN DISCOLOURATION 191 0.0042
713 ATAXIA 49 0.0041
714 BLOOD PRESSURE INCREASED 631 0.0041
715 UNRESPONSIVE TO STIMULI 106 0.0041
716 RASH GENERALISED 106 0.0041
717 EPISTAXIS 306 0.0041
718 POOR QUALITY SLEEP 88 0.0041
719 PNEUMONIA ASPIRATION 102 0.0041
720 HEPATIC FUNCTION ABNORMAL 152 0.0041
721 CONTUSION 392 0.0041
722 LABORATORY TEST ABNORMAL 120 0.0041
723 TOOTH DISORDER 90 0.0040
724 CYST 50 0.0040
725 ABSCESS 64 0.0040
726 TREATMENT FAILURE 332 0.0040
727 BURNING SENSATION 280 0.0040
728 SPINAL FRACTURE 80 0.0040
729 LIVER DISORDER 177 0.0040
730 BONE MARROW FAILURE 81 0.0040
731 EYE INFECTION 45 0.0040
732 UPPER GASTROINTESTINAL HAEMORRHAGE 67 0.0040
733 DRUG TOXICITY 54 0.0040
734 HEMIPARESIS 67 0.0040
735 DRUG INEFFECTIVE 5210 0.0039
736 DECREASED APPETITE 918 0.0039
737 JOINT RANGE OF MOTION DECREASED 53 0.0039
738 HERPES ZOSTER 227 0.0039
739 INSOMNIA 1052 0.0039
740 GLAUCOMA 76 0.0039
741 MIGRAINE 376 0.0039
742 RASH PAPULAR 88 0.0039
743 BLISTER 220 0.0039
744 DYSSTASIA 114 0.0039
745 TARDIVE DYSKINESIA 110 0.0039
746 FLATULENCE 221 0.0039
747 LETHARGY 224 0.0039
748 PROTEINURIA 74 0.0039
749 RASH MACULAR 136 0.0039
750 NOCTURIA 47 0.0039
751 AGITATION 282 0.0038
752 LACTIC ACIDOSIS 124 0.0038
753 POLLAKIURIA 159 0.0038
754 PRODUCT PRESCRIBING ISSUE 83 0.0038
755 APHASIA 115 0.0038
756 FATIGUE 2953 0.0038
757 DIABETES MELLITUS INADEQUATE CONTROL 67 0.0038
758 FEBRILE NEUTROPENIA 249 0.0037
759 PANCREATITIS 198 0.0037
760 DISEASE PROGRESSION 443 0.0037
761 STOMATITIS 227 0.0037
762 WEIGHT INCREASED 838 0.0037
763 PRODUCT DOSE OMISSION ISSUE 1099 0.0037
764 HIP FRACTURE 120 0.0037
765 TENDON RUPTURE 46 0.0037
766 ABASIA 92 0.0037
767 HYPOKINESIA 54 0.0037
768 SWELLING 347 0.0037
769 NEURALGIA 90 0.0037
770 URINARY INCONTINENCE 109 0.0037
771 PHOTOPHOBIA 69 0.0037
772 HYPERTHYROIDISM 53 0.0037
773 BONE LOSS 55 0.0037
774 PARANOIA 63 0.0037
775 HYPOAESTHESIA ORAL 55 0.0036
776 DISABILITY 72 0.0036
777 LOCALISED INFECTION 88 0.0036
778 BLOOD URINE PRESENT 69 0.0036
779 LIP SWELLING 121 0.0036
780 PRURITUS 1392 0.0036
781 DIZZINESS 1806 0.0036
782 SENSORY DISTURBANCE 58 0.0036
783 DYSARTHRIA 136 0.0036
784 HYPOGLYCAEMIA 175 0.0036
785 CRYING 131 0.0036
786 PARAESTHESIA 567 0.0036
787 RESPIRATORY ARREST 99 0.0036
788 MELAENA 79 0.0036
789 MUSCULOSKELETAL STIFFNESS 312 0.0036
790 MUSCLE SPASMS 648 0.0035
791 ILL-DEFINED DISORDER 214 0.0035
792 NERVOUSNESS 184 0.0035
793 HERNIA 68 0.0035
794 HAEMATEMESIS 89 0.0035
795 VISION BLURRED 481 0.0035
796 SKIN REACTION 49 0.0035
797 RESTLESSNESS 127 0.0035
798 ABORTION SPONTANEOUS 139 0.0035
799 PELVIC PAIN 63 0.0035
800 DRY MOUTH 281 0.0035
801 LOSS OF CONSCIOUSNESS 443 0.0035
802 HOSPITALISATION 529 0.0034
803 HYPOAESTHESIA 515 0.0034
804 POST PROCEDURAL COMPLICATION 66 0.0034
805 FALL 1141 0.0034
806 UNEVALUABLE EVENT 259 0.0034
807 EXTRAPYRAMIDAL DISORDER 85 0.0034
808 EYE PAIN 193 0.0034
809 GAIT DISTURBANCE 654 0.0034
810 IMPAIRED HEALING 112 0.0034
811 AGGRESSION 170 0.0034
812 DERMATITIS 71 0.0034
813 BACK DISORDER 55 0.0034
814 SKIN EXFOLIATION 285 0.0034
815 THYROID DISORDER 52 0.0034
816 JOINT STIFFNESS 88 0.0034
817 CONFUSIONAL STATE 541 0.0033
818 ROAD TRAFFIC ACCIDENT 140 0.0033
819 ARTHROPATHY 186 0.0033
820 DRY EYE 167 0.0033
821 SPEECH DISORDER 174 0.0033
822 DIPLOPIA 86 0.0033
823 FLUID RETENTION 168 0.0033
824 TASTE DISORDER 67 0.0033
825 INCREASED APPETITE 63 0.0033
826 DYSKINESIA 134 0.0033
827 GINGIVAL BLEEDING 45 0.0033
828 MUSCULAR WEAKNESS 374 0.0033
829 CYTOKINE RELEASE SYNDROME 66 0.0033
830 SKIN ULCER 85 0.0033
831 SEROTONIN SYNDROME 63 0.0033
832 BALANCE DISORDER 283 0.0033
833 OSTEONECROSIS OF JAW 81 0.0033
834 THERAPY PARTIAL RESPONDER 51 0.0033
835 FEEDING DISORDER 66 0.0033
836 PSYCHOMOTOR HYPERACTIVITY 54 0.0033
837 MYALGIA 547 0.0032
838 AMNESIA 208 0.0032
839 CIRCULATORY COLLAPSE 54 0.0032
840 CARDIAC DISORDER 296 0.0032
841 BONE PAIN 185 0.0032
842 FEELING ABNORMAL 756 0.0032
843 PRURITUS GENERALISED 68 0.0031
844 HEAD INJURY 99 0.0031
845 BLOOD CREATINE PHOSPHOKINASE INCREASED 90 0.0031
846 ARTHRALGIA 1295 0.0031
847 NERVOUS SYSTEM DISORDER 97 0.0031
848 HEPATIC CIRRHOSIS 58 0.0031
849 MUSCLE TIGHTNESS 50 0.0031
850 GLOSSODYNIA 69 0.0031
851 DISORIENTATION 122 0.0031
852 PRODUCT USE COMPLAINT 48 0.0030
853 MANIA 50 0.0030
854 SURGERY 178 0.0030
855 ABNORMAL BEHAVIOUR 120 0.0030
856 MENTAL IMPAIRMENT 73 0.0030
857 EYE DISORDER 99 0.0030
858 LIMB DISCOMFORT 93 0.0030
859 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 541 0.0030
860 PERIPHERAL SWELLING 461 0.0030
861 MEDICATION ERROR 166 0.0030
862 DISTURBANCE IN ATTENTION 161 0.0030
863 FEELING COLD 83 0.0030
864 WHITE BLOOD CELL COUNT DECREASED 322 0.0030
865 THIRST 53 0.0030
866 BLOOD PRESSURE DECREASED 197 0.0030
867 GENERALISED TONIC-CLONIC SEIZURE 49 0.0030
868 JOINT SWELLING 356 0.0029
869 NIGHTMARE 102 0.0029
870 GASTRIC DISORDER 101 0.0029
871 INFLUENZA LIKE ILLNESS 241 0.0029
872 NEUTROPENIA 397 0.0029
873 GASTROINTESTINAL HAEMORRHAGE 243 0.0029
874 OSTEONECROSIS 95 0.0029
875 COGNITIVE DISORDER 135 0.0029
876 ECZEMA 151 0.0029
877 LYMPHOCYTE COUNT DECREASED 51 0.0029
878 HEAD DISCOMFORT 51 0.0029
879 URINARY RETENTION 96 0.0029
880 MOBILITY DECREASED 206 0.0029
881 INTESTINAL OBSTRUCTION 108 0.0029
882 HYPERSOMNIA 82 0.0029
883 MOVEMENT DISORDER 91 0.0028
884 LOCAL SWELLING 49 0.0028
885 DEPRESSED LEVEL OF CONSCIOUSNESS 111 0.0028
886 VISUAL ACUITY REDUCED 93 0.0028
887 BLINDNESS 114 0.0028
888 ERUCTATION 54 0.0028
889 PRODUCT USE ISSUE 520 0.0028
890 OCULAR HYPERAEMIA 131 0.0028
891 FEELING HOT 169 0.0028
892 MUCOSAL INFLAMMATION 72 0.0027
893 HOT FLUSH 207 0.0027
894 SKIN CANCER 59 0.0027
895 SKIN DISORDER 91 0.0027
896 EYE IRRITATION 157 0.0027
897 CEREBROVASCULAR ACCIDENT 462 0.0027
898 INCORRECT PRODUCT ADMINISTRATION DURATION 59 0.0027
899 ANGER 92 0.0027
900 CARDIOVASCULAR DISORDER 69 0.0027
901 PLATELET COUNT DECREASED 289 0.0027
902 MYOCARDIAL INFARCTION 467 0.0027
903 THERAPEUTIC RESPONSE UNEXPECTED 120 0.0027
904 MEMORY IMPAIRMENT 361 0.0026
905 CARDIAC FAILURE 210 0.0026
906 CEREBRAL INFARCTION 63 0.0026
907 VISUAL IMPAIRMENT 319 0.0026
908 FEMUR FRACTURE 79 0.0025
909 PRODUCT AVAILABILITY ISSUE 58 0.0025
910 SUICIDAL IDEATION 233 0.0025
911 MOOD SWINGS 81 0.0025
912 ALTERED STATE OF CONSCIOUSNESS 55 0.0025
913 SYSTEMIC LUPUS ERYTHEMATOSUS 89 0.0025
914 MUSCLE TWITCHING 57 0.0025
915 FRACTURE 46 0.0024
916 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 71 0.0024
917 ERECTILE DYSFUNCTION 62 0.0024
918 THERAPEUTIC RESPONSE SHORTENED 80 0.0024
919 SOMNOLENCE 482 0.0024
920 FULL BLOOD COUNT DECREASED 48 0.0024
921 PLASMA CELL MYELOMA 92 0.0024
922 ABNORMAL DREAMS 65 0.0024
923 PSORIATIC ARTHROPATHY 94 0.0023
924 TOXICITY TO VARIOUS AGENTS 389 0.0023
925 NEUTROPHIL COUNT DECREASED 94 0.0023
926 PRODUCT ADMINISTRATION ERROR 46 0.0023
927 FLUSHING 229 0.0023
928 IRRITABILITY 134 0.0022
929 ADVERSE DRUG REACTION 200 0.0022
930 ACCIDENTAL OVERDOSE 81 0.0022
931 DERMATITIS ATOPIC 114 0.0022
932 INTENTIONAL PRODUCT USE ISSUE 189 0.0022
933 COMA 100 0.0021
934 MOOD ALTERED 57 0.0021
935 GAIT INABILITY 69 0.0021
936 THERAPEUTIC RESPONSE DECREASED 125 0.0021
937 SUICIDE ATTEMPT 124 0.0020
938 DEMENTIA 57 0.0020
939 DRUG ADMINISTRATION ERROR 62 0.0020
940 SEIZURE 231 0.0020
941 PHARMACEUTICAL PRODUCT COMPLAINT 51 0.0020
942 RHEUMATOID ARTHRITIS 221 0.0019
943 ALOPECIA 380 0.0019
944 CONTRAINDICATED PRODUCT ADMINISTERED 58 0.0019
945 VAGINAL HAEMORRHAGE 83 0.0019
946 CEREBRAL HAEMORRHAGE 68 0.0019
947 EPILEPSY 58 0.0019
948 DRY SKIN 249 0.0019
949 EXPOSURE VIA SKIN CONTACT 48 0.0019
950 BLOOD GLUCOSE INCREASED 329 0.0017
951 DEVICE DELIVERY SYSTEM ISSUE 47 0.0017
952 NEEDLE ISSUE 49 0.0017
953 INCORRECT DRUG ADMINISTRATION DURATION 46 0.0016
954 INTENTIONAL PRODUCT MISUSE 142 0.0016
955 DEATH 1366 0.0016
956 BLOOD GLUCOSE DECREASED 72 0.0015
957 THERAPEUTIC PRODUCT EFFECT DECREASED 67 0.0015
958 PRODUCT QUALITY ISSUE 203 0.0015
959 NEOPLASM MALIGNANT 98 0.0015
960 ADVERSE EVENT 135 0.0015
961 EXTRA DOSE ADMINISTERED 59 0.0015
962 INJECTION SITE PRURITUS 95 0.0014
963 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 284 0.0014
964 INCORRECT DOSE ADMINISTERED 319 0.0014
965 PSORIASIS 180 0.0014
966 MYELOSUPPRESSION 49 0.0014
967 INJECTION SITE SWELLING 103 0.0013
968 DEVICE ISSUE 119 0.0013
969 INJECTION SITE REACTION 86 0.0012
970 INJECTION SITE PAIN 382 0.0012
971 OVERDOSE 268 0.0012
972 WITHDRAWAL SYNDROME 52 0.0012
973 NO ADVERSE EVENT 223 0.0012
974 ACNE 93 0.0012
975 INJECTION SITE ERYTHEMA 144 0.0012
976 SKIN IRRITATION 53 0.0012
977 DEVICE DISLOCATION 50 0.0011
978 INJECTION SITE BRUISING 87 0.0011
979 INTENTIONAL OVERDOSE 69 0.0011
980 MALIGNANT NEOPLASM PROGRESSION 107 0.0010
981 DRUG DOSE OMISSION 162 0.0010
982 UNDERDOSE 70 0.0010
983 DRUG WITHDRAWAL SYNDROME 83 0.0009
984 DRUG EFFECT DECREASED 50 0.0009
985 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 65 0.0009
986 PRODUCT SUBSTITUTION ISSUE 52 0.0009
987 SKIN BURNING SENSATION 64 0.0009
988 DRUG DOSE OMISSION BY DEVICE 66 0.0008
989 DRUG DEPENDENCE 126 0.0008
990 DRUG ABUSE 55 0.0007
991 PRODUCT STORAGE ERROR 57 0.0007
992 ACCIDENTAL EXPOSURE TO PRODUCT 66 0.0006
993 INJECTION SITE HAEMORRHAGE 45 0.0006
994 BREAST CANCER 46 0.0005